drugset / Trial / NCT00828646
Safety Study of Multiple-dose of Gamma-secretase Inhibitor in Healthy Male Japanese and Healthy Elderly Japanese
RandomizedParallel-groupTriple-blindTreatment
Summary
The purpose of this study is to evaluate the safety profile, tolerability, pharmacokinetics, and pharmacodynamics following 14-day multiple oral doses BMS-708163 in healthy young male Japanese and healthy elderly male and female Japanese subjects
Timeline
- Start
- 2008-10
- Primary completion
- 2009-07
- Completion
- 2009-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Avagacestat | Small molecule | 50 mg | Oral |
| Subject | Avagacestat | Small molecule | 75 mg | Oral |
| Subject | Avagacestat | Small molecule | 100 mg | Oral |
Indications
No indication recorded.